At the completion of the complaint investigation, based on the information received, the clinical assessment was able to confirm a type 3b endoleak of the main body and proximal cuff devices.Additionally a clinical evaluation was able to identify a dilation of the main body stent and refute the dilation of the suprarenal stent.The most likely cause of the type 3b endoleak of the main body and cuff was related to the use of strata material.There were no procedure related harms identified due to the lack of medical information surrounding both the implant and the event.To date the patient has not had a secondary procedure.The event devices remain implanted in the patient and were not available for further evaluation.The review of the manufacturing lot confirmed all devices met specifications prior to release.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.
|